Facebook
Twitter
LinkedIn
ForwardAsthma Courses
| Activity Title | Credit | Cost |
|---|---|---|
| Virtual Patient: Asthma in the Older Adult |
|
$0.00 |
| Plenary 2101: New Paradigms in the Management of Severe Asthma |
|
$0.00 |
| VAM 20 2310: Systems Analysis of Viral Infection and Asthma |
|
$15.00 |
| VAM 20 2302: Emerging Concepts in Childhood Asthma Exacerbations |
|
$15.00 |
| VAM 20 2552 Pro/Con Debate: Asthma Biologics are Cost Effective for Severe Asthma |
|
$15.00 |
| VAM 20 1510: JACI: In Practice Year-in-Review Workshop |
|
$15.00 |
| Virtual Patient: Care of an Older Adult with Asthma During the COVID-19 Pandemic |
|
$0.00 |
Asthma Resources for Healthcare Providers
Additional Online Education
Foundations of Asthma (AAAAI/Medscape collaborative learning series):
Expanding the Role for Biomarkers in Managing Therapy
Exploring the Allergic Component in Management
When to Consider and Initiate Biologic Therapies (Coming Soon!)
AAP Year-in-Review Workshop: Hot Topics in Pediatric Allergy/Immunology(MOC)
Asthma IQ: These performance improvement modules help you to improve your compliance with the EPR-3 Guidelines and satisfy MOC requirements: Asthma IQ: Patient Assessment and Asthma IQ: Patient Management and Outcomes.
SAMPROTM: Improving Asthma Management in Schools - A Practice Improvement Module
Clinical Resources
Referral Guidelines for Asthma
School Tools: Allergy & Asthma Resources for Professionals
The Office of School-Based Management of Asthma (SAMPRO™): A Comprehensive Asthma Educational Resource
Quality Clinical Data Registry
Action Plan (English)
Action Plan (Spanish)
Practice Parameters
Asthma Practice Parameter (1995)
Algorithm for the Diagnosis and Management of Asthma: a practice parameter update (1998)
Attaining optimal asthma control: a practice parameter (2005)
Management of acute loss of asthma control in the yellow zone: a practice parameter (2014)
Exercise-Induced Bronchoconstriction Practice Parameter (2016)
Asthma Resources including an asthma overview, explanation of symptoms and diagnosis, treatment and management, an action plan, information for patients, and more.
Free, non-credit bearing Virtual Annual Meeting sessions
1503: ILC2: Gateway to Th2 Inflammation
1601: The Origins of Childhood Asthma
1804: B-Regulatory Cells: No Longer Playing Second Fiddle to T Regs
2302: Lessons from Performing Guideline-Drive, Evidence-Based Asthma Interventions in the Real World: Who Benefits?
2551: Rhinovirus is More Important Than RSV in the Origin of Asthma
3701: ADT: Asthma Endotypes: What are the Therapeutic Implications?
3703: EORD: Importance of School Environments for Children with Asthma
4304: Phospholipases A2 and Lipid Mediators in the Pathogenesis of Asthma
Collaborate with Asthma Professionals
Interested in collaborating with fellow AAAAI members who share a particular interest in Asthma Education? The Asthma Diagnosis and Treatment (ADT) Interest Section is the community for AAAAI members interested in advancing the knowledge and understanding of asthma diagnosis and treatment. Topics covered include: allergen specific and non-specific bronchoprovocation, allergic and immunologic assessment and imaging studies, allergic bronchopulmonary aspergillosis, exercise-induced bronchoconstriction and exercise testing, inhalation delivery devices, pharmacologic and immunologic therapy.
To learn more about the work of this interest section, contact one of the leaders below:
Chair Caroline C. Horner, MD FAAAAI
Vice Chair Sharmilee M. Nyenhuis, MD FAAAAI
Secretary Thanai Pongdee, MD FAAAAI
Staff Liaison Renee Vandlik
Interested in aligning with ADT?
Becoming part of the ADT community network is as simple as linking to your AAAAI personal member profiles and updating your profile to reflect your primary membership as ADT under the tab labeled Involvement.
Or, consider the work of the Asthma, Cough, Diagnosis and Treatment Committee. Its purpose is to promote education concerning the diagnosis, assessment and treatment of asthma and cough. NOTE: Interest Section Committees are open to all members of the AAAAI.